Novel proteinaceous infectious particles cause scrapie, Science, vol.216, issue.4542, pp.136-180, 1982. ,
Molecular pathology of human prion diseases, Int J Mol Sci, vol.10, issue.3, pp.976-99, 2009. ,
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy, Biochemistry, vol.30, issue.31, pp.7672-80, 1991. ,
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins, Proc Natl Acad Sci, vol.90, issue.23, pp.10962-10968, 1993. ,
A novel human disease with abnormal prion protein sensitive to protease, Ann Neurol, vol.63, issue.6, pp.697-708, 2008. ,
A case of protease sensitive prionopathy in a patient in the UK, Neuropathol Appl Neurobiol, vol.35, issue.6, pp.628-660, 2009. ,
The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype, J Neurol Neurosurg Psychiatry, vol.81, issue.9, pp.1052-1057, 2010. ,
Variably proteasesensitive prionopathy: a new sporadic disease of the prion protein, Ann Neurol, vol.68, issue.2, pp.162-72, 2010. ,
Eight prion strains have PrP(Sc) molecules with different conformations, Nat Med, vol.4, issue.10, pp.1157-65, 1998. ,
Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes, Biochemistry, vol.41, issue.42, pp.12868-75, 2002. ,
Diagnosis of human prion disease, Proc Natl Acad Sci U S A, vol.102, issue.9, pp.3501-3507, 2005. ,
Isolation and characterization of a proteinase K-sensitive PrPSc fraction, Biochemistry, vol.45, issue.51, pp.15710-15717, 2006. ,
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders, Annu Rev Neurosci, vol.26, pp.267-98, 2003. ,
The most infectious prion protein particles, Nature, vol.437, issue.7056, pp.257-61, 2005. ,
In vitro and in vivo neurotoxicity of prion protein oligomers, PLoS Pathog, vol.3, issue.8, p.125, 2007. ,
Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity, J Neurosci, vol.31, issue.42, pp.14882-92, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00635922
Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions, Curr Top Med Chem, vol.13, pp.2477-83, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01104775
Improved synthesis of a quaterthiophenetriazine-diamine derivative, a promising molecule to study pathogenic prion proteins, Tetrahedron Lett, vol.56, issue.2, pp.368-73, 2015. ,
The same primary structure of the prion protein yields two distinct self-propagating states, J Biol Chem, vol.283, issue.23, pp.15988-96, 2008. ,
Two amyloid States of the prion protein display significantly different folding patterns, J Mol Biol, vol.400, issue.4, pp.908-929, 2010. ,
Therapeutic approaches for prion disorders, Expert Rev Anti Infect Ther, vol.5, issue.4, pp.613-643, 2007. ,
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease, Acta Neuropathol, vol.125, issue.6, pp.795-813, 2013. ,
Small-molecule conversion of toxic oligomers to nontoxic ?-sheet-rich amyloid fibrils nature chemical biology, Nat Chem Biol, vol.8, pp.93-101, 2012. ,
Ferulic acid inhibits the transition of amyloid-beta42 monomers to oligomers but accelerates the transition from oligomers to fibrils, J Alzheimers Dis, vol.37, issue.1, pp.19-28, 2013. ,
The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates, Chemistry, vol.19, issue.31, pp.10179-92, 2013. ,
Pentameric thiophene-based ligands that spectrally discriminate amyloid-beta and tau aggregates display distinct solvatochromism and viscosity-induced spectral shifts, Chemistry, vol.20, issue.39, pp.12537-12580, 2014. ,
Tissue distribution of protease resistant prion protein in variant CreutzfeldtJakob disease using a highly sensitive immunoblotting assay, Lancet, vol.358, issue.9277, pp.171-80, 2001. ,
Structure-based drug design identifies polythiophenes as antiprion compounds, Sci Transl Med, vol.7, issue.299, pp.299-123, 2015. ,
Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein, J Virol, vol.74, issue.1, pp.320-325, 2000. ,
Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation, J Neurochem, vol.89, issue.2, pp.454-63, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00143226
High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility, Eur J Biochem, vol.267, issue.10, pp.2833-2842, 2000. ,
In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc), J Mol Biol, vol.346, issue.2, pp.645-59, 2005. ,
Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways, FEBS J, vol.275, issue.9, pp.2021-2052, 2008. ,
Paxinos and Franklin's the mouse brain in stereotaxic coordinates, 2012. ,
Linkage of prion protein and scrapie incubation time genes, Cell, vol.46, issue.4, pp.503-514, 1986. ,
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques, Cell, vol.59, issue.5, pp.847-57, 1989. ,
Techniques in prion research, Birhauser Basel, pp.82-96, 2004. ,
Effective gene therapy in a mouse model of prion diseases, PLoS One, vol.3, issue.7, p.2773, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01667611